pre-IPO PHARMA

COMPANY OVERVIEW

Limelight Bio, Inc. is an emerging biotech company developing novel gene therapies that greatly expand the utility of clinically-validated AAV vectors to enable the treatment of debilitating inherited diseases that cannot be addressed by current technologies; such as those caused by mutations in large genes and autosomal dominant inheritance patterns.


LOCATION

  • Philadelphia, PA, USA

  • THERAPEUTIC AREAS


    WEBSITE

    https://www.limelightbio.com


    CAREER WEBSITE


    SOCIAL MEDIA


    INVESTORS

    apple-tree-partners


    PRESS RELEASES


    Dec 5, 2019

    Limelight Bio Emerges with $75 Million to Develop Next Generation Gene Therapies to Overcome Limitations of Current Treatments


    Dec 5, 2019

    Limelight Bio Emerges with $75 Million to Develop Next Generation Gene Therapies to Overcome Limitations of Current Treatments


    For More Press Releases


    Google Analytics Alternative